
    
      PROTOCOL OUTLINE: This is a randomized, double blind, placebo controlled, crossover study.
      All patients receive oral placebo daily during week 0.

      Patients are randomized to receive either oral fluoxetine or oral placebo daily on weeks 1-8.
      Patients then crossover to receive treatment on the other arm during weeks 12-20.

      Completion date provided represents the completion date of the grant per OOPD records
    
  